MARKET

MDWD

MDWD

Mediwound
NASDAQ
16.22
-0.04
-0.22%
Opening 10:06 05/14 EDT
OPEN
16.23
PREV CLOSE
16.25
HIGH
16.24
LOW
16.10
VOLUME
9.73K
TURNOVER
--
52 WEEK HIGH
22.51
52 WEEK LOW
14.90
MARKET CAP
208.40M
P/E (TTM)
-7.7251
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MDWD last week (0504-0508)?
Weekly Report · 3d ago
MediWound to report first-quarter 2026 results, hosts conference call and webcast
PUBT · 05/07 12:00
MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting
TipRanks · 05/06 20:34
Weekly Report: what happened at MDWD last week (0427-0501)?
Weekly Report · 05/04 09:55
Weekly Report: what happened at MDWD last week (0420-0424)?
Weekly Report · 04/27 09:57
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
TipRanks · 04/23 14:00
Weekly Report: what happened at MDWD last week (0413-0417)?
Weekly Report · 04/20 09:54
MediWound: EscharEx Phase III Upside and NexoBrid Traction Support Compelling Buy Thesis
TipRanks · 04/13 19:25
More
About MDWD
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Webull offers Mediwound Ltd stock information, including NASDAQ: MDWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDWD stock methods without spending real money on the virtual paper trading platform.